GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Genomtec SA (WAR:GMT) » Definitions » Liabilities-to-Assets

Genomtec (WAR:GMT) Liabilities-to-Assets : 0.48 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Genomtec Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Genomtec's Total Liabilities for the quarter that ended in Dec. 2023 was zł7.67 Mil. Genomtec's Total Assets for the quarter that ended in Dec. 2023 was zł15.97 Mil. Therefore, Genomtec's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2023 was 0.48.


Genomtec Liabilities-to-Assets Historical Data

The historical data trend for Genomtec's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomtec Liabilities-to-Assets Chart

Genomtec Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Liabilities-to-Assets
Get a 7-Day Free Trial 0.62 0.19 0.83 0.58 0.48

Genomtec Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 0.74 0.39 0.46 0.48

Competitive Comparison of Genomtec's Liabilities-to-Assets

For the Medical Devices subindustry, Genomtec's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomtec's Liabilities-to-Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Genomtec's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Genomtec's Liabilities-to-Assets falls into.



Genomtec Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Genomtec's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Liabilities-to-Assets (A: Dec. 2023 )=Total Liabilities/Total Assets
=7.67/15.972
=0.48

Genomtec's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2023 is calculated as

Liabilities-to-Assets (Q: Dec. 2023 )=Total Liabilities/Total Assets
=7.67/15.972
=0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genomtec  (WAR:GMT) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Genomtec Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Genomtec's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomtec (WAR:GMT) Business Description

Traded in Other Exchanges
Address
ul. Stab?owicka 147, PORT Building 2, Wroclaw, POL, 54-066
Genomtec SA is an innovative technology company which works in the area of ?? molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.

Genomtec (WAR:GMT) Headlines

No Headlines